NOVT
Novanta Inc.
Is NOVT Halal?
Permissible precision-technology manufacturing business with passing known asset ratios, but current filing-based activity and income data remain incomplete.
What You Should Know
Novanta Inc. designs and manufactures precision photonics, vision and motion components for medical, life-science and industrial equipment. Its April 3, 2026 Form 10-Q reports assets of $1,799.055 million, interest-bearing debt of $241.421 million, cash of $388.799 million and accounts receivable of $173.934 million. Debt/assets is 13.42%, liquidity/assets is 21.61% and receivables-plus-cash/assets is 31.28%; gross interest income and a reproducible prohibited-revenue numerator are not separately disclosed. The known ratios pass the examined MSCI and Malaysia proxies, but activity and FTSE income treatment remain incomplete, so the stored result is doubtful rather than an unconditional halal certification.
⚠️ Concerns
- •Known debt, liquidity and receivables-plus-cash ratios pass the examined asset limits
- •Acquisition financing and medical-device end uses require ongoing review
- •Gross interest income and a universal prohibited-revenue numerator are unavailable
- •Component applications vary by customer and contract
- •Re-screen after the next filing or a material acquisition
Current quantitative Sharia screen
Based on 10-Q figures for the period ended 2026-04-03; calculated 2026-07-15.
241.421 / 1,799.055
388.799 / 1,799.055
562.733 / 1,799.055
- Financial
- Incomplete
- Overall
- Incomplete
Debt/assets is 13.42%, liquidity is 21.61% and receivables plus cash is 31.28%, below examined FTSE limits, but gross interest income is unavailable.
- Financial
- Pass
- Overall
- Incomplete
Debt/assets is 13.42%, liquidity is 21.61% and receivables plus cash is 31.28%, below examined MSCI total-assets limits; activity remains incomplete.
- Financial
- Pass
- Overall
- Incomplete
Debt/assets is 13.42% and liquidity is 21.61%, below the examined 33% limits; activity remains incomplete and this is not an official classification.
- Financial
- Not calculated
- Overall
- Incomplete
A licensed historical market-cap series is not stored and activity classification remains incomplete.
Business-activity disclosure
Novanta manufactures precision photonics, vision and motion components for medical, life-science and industrial equipment. Enabling-technology manufacturing is generally permissible, while customer end uses require review.
Limitation: The filing does not provide a reproducible prohibited-revenue numerator for medical, industrial or customer end uses, and gross interest income is not separately disclosed.
Purification
Gross interest income is not separately disclosed and no scholar-approved purification percentage is inferred.
Inputs, assumptions and primary sources
- Amounts are USD millions converted from Novanta's thousands-of-dollars presentation for April 3, 2026.
- Debt combines $40.416 million current and $201.005 million long-term debt; operating leases are excluded.
- Cash is $388.799 million and no separately identified interest-bearing securities are added.
- Accounts receivable is $173.934 million and first-quarter revenue is $257.707 million; gross interest income is not separately disclosed.
- The filing is Novanta's first fiscal quarter ended April 3, 2026.
This is a reproducible financial screen, not a fatwa. A failed total-assets screen can coexist with a pass under a market-cap methodology. ZakatInvest keeps the qualitative assessment separate so numerical thresholds do not erase material context.
Similar Stocks
Want to screen more assets?
Use our interactive Halal Checker to screen any stock, ETF, or crypto instantly.
Go to Halal Checker →